A new publication by the GRAPPA–OMERACT group provides recommendations and a useful framework for physicians on the use of composite measures and treatment targets in psoriatic arthritis. However, these recommendations highlight the need for more research in order to improve patient care and health-related quality of life.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Scarpa, R. et al. Psoriatic disease 10 years later. J. Rheumatol. 44, 1298–1301 (2017).
Coates, L. C. et al. GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. Arthritis Rheumatol. https://doi.org/10.1002/art.40391 (2017).
Orbai, A. M. et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann. Rheum. Dis. 76, 673–680 (2016).
Kirwan, J. R., Boers, M. & Tugwell, P. Updating the OMERACT filter at OMERACT 11. J. Rheumatol. 41, 975–977 (2014).
Helliwell, P. S. et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann. Rheum. Dis. 72, 986–991 (2013).
Mumtaz, A. et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann. Rheum. Dis. 70, 272–277 (2011).
Nell-Duxneuner, V. P. et al. Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis. Ann. Rheum. Dis. 69, 546–549 (2010).
Pincus, T., Swearingen, C. J., Bergman, M. & Yazici, Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J. Rheumatol. 35, 2136–2147 (2008).
Coates, L. C., Fransen, J. & Helliwell, P. S. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann. Rheum. Dis. 69, 48–53 (2010).
Coates, L. C. et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 68, 1060–1071 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Scarpa, R., Caso, F. Which composite measures to use in psoriatic arthritis?. Nat Rev Rheumatol 14, 125–126 (2018). https://doi.org/10.1038/nrrheum.2018.15
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2018.15
This article is cited by
-
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study
Rheumatology International (2020)
-
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study
Clinical Rheumatology (2020)
-
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management
Drugs & Aging (2019)
-
Psoriatic disease treatment nowadays: unmet needs among the “jungle of biologic drugs and small molecules”
Clinical Rheumatology (2018)